Aratana Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,287.00
38,816.00
84,054.00
33,575.00
47,510.00
14,722
Depreciation, Depletion & Amortization
395.00
2,043.00
1,840.00
991.00
1,162.00
990
Other Funds
2,617.00
15,166.00
3,000.00
-
184.00
8,581
Funds from Operations
18,001.00
29,486.00
38,339.00
10,776.00
30,559.00
5,151
Changes in Working Capital
1,850.00
2,702.00
156.00
547.00
7,626.00
6,110
Net Operating Cash Flow
16,151.00
32,188.00
38,495.00
11,323.00
38,185.00
11,261
Capital Expenditures
94.00
471.00
2,245.00
1,072.00
6,001.00
Purchase/Sale of Investments
1,712.00
85,422.00
35,908.00
58,451.00
249.00
Net Investing Cash Flow
29,235.00
100,125.00
33,663.00
57,285.00
5,752.00
Issuance/Reduction of Debt, Net
14,914.00
18,067.00
24,779.00
-
3,710.00
Net Financing Cash Flow
72,497.00
100,978.00
21,895.00
14,632.00
23,471.00
Net Change in Cash
27,111.00
31,261.00
16,932.00
60,552.00
20,439.00
Free Cash Flow
16,245.00
32,659.00
40,740.00
11,395.00
38,186.00
Deferred Taxes & Investment Tax Credit
15,455.00
1,443.00
1,698.00
-
-
-
Net Assets from Acquisitions
30,994.00
12,075.00
-
94.00
-
Other Sources
141.00
-
-
-
-
Change in Capital Stock
60,200.00
134,211.00
116.00
14,632.00
27,365.00
Exchange Rate Effect
-
74.00
131.00
42.00
27.00
Other Uses
-
2,157.00
-
-
-
About Aratana Therapeutics
View Profile
